NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) went up by 10.16% from its latest closing price compared to the recent 1-year high of $4.70. The company’s stock price has collected -0.37% of loss in the last five trading sessions. Press Release reported on 01/04/22 that NeuroSense Therapeutics, Ltd. Announces the Presentation of Phase IIa Study Results at Four International Conferences
Is It Worth Investing in NeuroSense Therapeutics Ltd. (NASDAQ :NRSN) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for NeuroSense Therapeutics Ltd. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $7.00. NRSN currently public float of 6.29M and currently shorts hold a 1.50% ratio of that float. Today, the average trading volume of NRSN was 395.60K shares.
NRSN’s Market Performance
The volatility ratio for the week stands at 8.17% while the volatility levels for the past 30 days are set at 9.90% for NeuroSense Therapeutics Ltd.. The simple moving average for the period of the last 20 days is 6.47% for NRSN stocks with a simple moving average of 2.79% for the last 200 days.
NRSN Trading at 2.79% from the 50-Day Moving Average
After a stumble in the market that brought NRSN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.25% of loss for the given period.
Volatility was left at 9.90%, however, over the last 30 days, the volatility rate increased by 8.17%, as shares sank -18.16% for the moving average over the last 20 days.
During the last 5 trading sessions, NRSN rose by +6.46%, in comparison to the 20-day moving average, which settled at $2.78. In addition, NeuroSense Therapeutics Ltd. saw 10.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NRSN
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.08.